NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (NASDAQ: SDIX) - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, today announced that its Board of Directors has approved a program to repurchase up to $3.0 million of the Company’s outstanding shares of common stock from time to time over the next 12 months, depending on market conditions, share price and other factors.
